W.R. Berkley CorporationNYSE: WRB
Financials · Property & Casualty Insurance
$67.21
-1.29%
Vol: 1.5M
Research Digest
Friday, June 19, 2026
WR Berkley founder dies at 80, Goldman Sachs upgrades to Buy, and company declares special dividend — leadership transition underway.
William R. Berkley, founder and Executive Chairman of WR Berkley Corp, passed away on June 9, 2026 at age 80, capping a nearly six-decade career building the company into a Fortune 500 insurer. The Board responded swiftly by appointing CEO W. Robert Berkley Jr. as Chairman, signaling continuity. Goldman Sachs upgraded WRB to Buy from Neutral on June 8, raising its price target to $73, citing more sustainable underwriting margins and ROE. The company also declared a quarterly dividend of $0.60 (up 1.7% YoY) plus a special cash dividend of $0.50 per share, both payable July 2 with an ex-date of June 23. WRB also amended its revolving credit facility on June 9. Key risk: leadership transitions at founder-led insurers can unsettle culture and investor sentiment near-term.
Previous Market Intelligence
13 daysJun 18No significant overnight updatesNeutral▶
No material news in the last 48 hours.
Jun 17No significant overnight updatesNeutral▶
No material news in the last 48 hours.
Jun 16No significant overnight updatesNeutral▶
No material news in the last 48 hours.
Jun 15No significant overnight updatesNeutral▶
No material news in the last 48 hours.
Jun 14Barclays trims W.R. Berkley's price target to $62 (Underweight) on June 12, days after the death of founder William R. Berkley.Negative▶
W.R. Berkley (WRB) drew fresh analyst action when Barclays' Alex Scott maintained an Underweight rating and lowered the price target to $62 from $64 on June 12, 2026, an implied downside call amid competitive pressure in commercial insurance. The move follows the June 9 announcement that founder and Executive Chairman William R. Berkley died at 80, after which the board named President and CEO W. Robert Berkley, Jr. as Chairman to preserve leadership continuity. The company also recently extended its revolving credit facility maturity to June 9, 2031, raised its regular quarterly dividend 11.1% to $0.10, and declared a $0.50 special dividend. Fundamentals remain strong, with record Q1 2026 results featuring a 21.2% return on equity and roughly 30.6% annualized five-year EPS growth. The bear case, reflected in the Barclays cut and earlier Hold downgrades from Argus and UBS, is that intensifying competition and a premium valuation cap upside even as governance transitions add uncertainty.
May 21WR Berkley shares jumped 3.5% on May 18 to $68.76 as 21.2% Q1 ROE narrative gains tractionPositive▶
WRB shares rose 3.5% on May 18 to $68.76 as investors re-engaged with the Q1 2026 record results showing 21.2% ROE, net income up 23.4% YoY to $515.2M, record operating income of $514.3M, and Q1 EPS of $1.30 versus the $1.14 consensus. Management is shifting focus from rate to growth in select lines amid rising competition, while maintaining capital returns. Stock remains down 4.2% YTD. The next earnings date is July 21. Consensus analyst rating is Hold with average 12-month PT of $68.86. Risk: shift toward growth from rate discipline could signal pricing pressure in commercial P&C, and softening reserve adequacy is a watch item.
May 20W.R. Berkley shares rose 3.5% on May 18 with insider purchases of $155.5M and Argus downgrade amid competitive insurance pressureMixed▶
W.R. Berkley shares rose 3.5% on May 18, 2026 to $68.76, trading within a 52-week range of $63.68-$78.96. Insider activity has been notable, with $155.5M in purchases over the last three months and no selling, suggesting management confidence. Q1 2026 delivered record results with strong net income, investment gains, underwriting profits, and a 21.2% return on equity; revenue was $3.69B vs $3.19B consensus. However, sentiment is mixed: UBS lowered its target to $68 from $69 on April 27, and Argus cut to Hold citing competitive pressure. Management is shifting focus from rate to growth in select lines as competition rises. Average rating Hold with $68.86 mean price target.
May 19No significant overnight updatesNeutral▶
No material news in the last 48 hours.
May 18WR Berkley shares hovered around $66.74 on May 15 after record Q1 with 21.2% ROE; BofA, KBW lifted PTs while Wells Fargo trimmed to $64.Positive▶
WR Berkley delivered a record first quarter with operating income up sharply, a 21.2% annualized return on equity, and EPS of $1.30 vs $1.14 consensus on $3.69B revenue. Average rate increases (ex-workers' comp) came in around 7.2%, well ahead of broader benchmarks. Net investment income advanced 12.2% to a record $404.3M. The company returned $336.1M to shareholders, including $302.4M in buybacks (~4.5M shares) and $33.7M in dividends. Following results, BofA raised its PT to $68 (Neutral), KBW raised to $67 (Market Perform), and Wells Fargo cut to $64 (Equal Weight). Shares traded near $66.74 on May 15, 2026, but remain down 4.2% YTD.
May 15W.R. Berkley trades $66-$67 in May; Mitsui Sumitomo lifts stake by $39.3M after disciplined Q1 ROE and ~14% Q1 EPS beatNeutral▶
W.R. Berkley shares traded $66.04-$66.77 on May 12 (~$65.68 on May 8), with insurance peers digesting Q1 2026 results that showed EPS of $1.30, beating the $1.14 consensus by 14% and producing a Q1 ROE in line with 2025. Mitsui Sumitomo Insurance disclosed an increase in its WRB stake by approximately $39.3M, a notable strategic vote of confidence from a global insurer. The board declared a regular $0.09/share quarterly dividend. Late-April analyst actions remain the active sell-side backdrop: UBS lowered PT to $68 from $69 and Argus cut to Hold citing competitive pressure in commercial P&C. Average analyst PT stands at $68.64 (Hold consensus across 15 analysts). Next earnings July 16, 2026.
May 14Zacks Research cut Q2 2026 EPS estimates for W.R. Berkley on May 12, sending mixed signals after record Q1 resultsMixed▶
Zacks Research lowered Q2 2026 earnings estimates for W.R. Berkley on May 12, suggesting moderating momentum after Q1 record results. The specialty insurer posted Q1 operating income of $514.3M ($1.30 EPS) vs $420M ($1.05) prior year, with 21.2% annualized ROE. Net investment income rose 12.2% to a record $404.3M. Despite strong Q1, analyst consensus is Reduce with average target of $68.81. Risk: softening US commercial market could compress rates. International Assets Investment Management disclosed a new 7,958-share stake.
May 13No significant overnight updatesNeutral▶
No material news in last 48 hours.
May 12W.R. Berkley reported a record Q1 with operating income of $514.3M ($1.30 diluted EPS) and a 21.2% annualized ROE, while Mitsui Sumitomo took at least a 12.5% stake.Positive▶
Q1 2026 operating income rose to a record $514.3M, or $1.30 diluted EPS, from $1.05 a year earlier. Gross premiums written rose to $3.79B and net investment income advanced 12.2% to a record $404.3M. The combined ratio was 90.7% and the company returned $336.1M to shareholders through buybacks ($302.4M) and dividends. Mitsui Sumitomo Insurance has acquired at least 12.5% of WRB shares. The stock currently trades near $66.32 with mixed analyst sentiment averaging Reduce and a consensus target of $68.81.
Sector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| WRBWR | $67.21 | -1.29% | — | 15.0x | 0.29 | $26.8B |
| CBCHUBB | $323.99 | -1.21% | — | 12.3x | 0.41 | $140.1B |
| PGRPROGRESSIVE | $203.88 | -0.26% | — | 14.1x | 0.25 | $135.2B |
| TRVTRAVELERS | $307.22 | +0.37% | — | 12.0x | 0.47 | $72.8B |
| ALLALLSTATE | $220.59 | -0.48% | — | 9.5x | 0.17 | $64.4B |
| HIGHARTFORD | $128.21 | -1.10% | — | 9.8x | 0.47 | $37.8B |
Key Fundamentals
RSI (14-Day)
52-Week Range
Moving Averages
Price below 200d MA — bearish structure.